Company / Total Assets
10x Genomics, Inc. Total Assets History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$1.0B
FY2025
5-year range
$918.6M / $1.0B
FY2021-FY2025
Trend
+13.4%
vs FY2024
Sector context
#118 of 166
Health Care
What the data says
At $1.0B, 10x Genomics, Inc.'s total assets ranks #118 of 166 in the Health Care sector. Total Assets returned to growth in FY2025 after 2 years of decline, reaching $1.0B.
Based on SEC 10-K filings.
$1.0B in FY2025 with a 5-year CAGR of +2.3%.
Improved from $965M to $1.0B over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +0.4%
- 5-Year CAGR
- +2.3%
- 10-Year CAGR
- -
Sector benchmark
#118 of 166 in Health CareTop 71% of 166This company $1.0B Sector average $15.0B
▼
-93.0% below sector average
Key checks
Key Insights
- 5-year CAGR of +2.3%, indicating consistent growth.
- In FY2025, total assets increased 13.4% year-over-year.
- Ranks #118 out of 166 companies in the Health Care sector.
- Lowest total assets in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -29.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.0B | +13.4% |
| FY2024 | $918.6M | -4.8% |
| FY2023 | $965.1M | -6.2% |
| FY2022 | $1.0B | +1.0% |
| FY2021 | $1.0B | +9.6% |
| FY2020 | $929.3M | +53.4% |
| FY2019 | $605.9M | +387.4% |
| FY2018 | $124.3M | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026